Research shows that S.L. enhances the 5-fluorouracil sensitivity and overcomes chemoresistance in 5-fluorouracil-resistant colorectal cancer cells via Ras/MEK/ERK and PI3K/Akt pathways (31). This evidence concerns the gene MAP2K7 and colorectal cancer.